In the world of Medical Affairs, today’s hybrid engagement environment has created new methods of communication between biopharma companies and practitioners to enhance engagement. In a recent interview, Christine Hoffman, Global Head of Medscape Medical Affairs, discusses ways to create more meaningful interactions with your KOLs to create real sustainable value
